日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

PDZK1-ULK1 Axis Triggers Lipophagy to Inhibit Tumor Progression and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

PDZK1-ULK1轴触发脂质自噬以抑制透明细胞肾细胞癌的肿瘤进展和舒尼替尼耐药性

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202511606
Qi, Xuan; Guo, Yu; Yang, Yumeng; Wang, Haibo; Yang, Xiaomei; Song, Ran; Qin, Qiong; Zhang, Yan; Hu, Meihan; Zhou, Haixing; Feng, Duiping; He, Junqi
肿瘤
肿瘤免疫
ULK1
肾癌
细胞生物学
自噬
发表日期：2026
文献求助 收藏

SIRT3 suppresses renal cancer progression by regulating IDH2 acetylation.

SIRT3 通过调节 IDH2 乙酰化来抑制肾癌的进展。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-37783-6
Li Lei, Tian Yongjiao, Chen Shu, Yu Jin, Chen Ziyu, Feng Duiping, Bai Tao
肿瘤
表观遗传
肿瘤免疫
肾癌
乙酰化
发表日期：2026
文献求助 收藏

MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker

MAGI3通过抑制MAS/ERK通路增强肾细胞癌对舒尼替尼的敏感性，并可作为预后标志物。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07427-0
Wang, Haibo; Chen, Yibin; Yang, Ying; Song, Ran; Gu, Siyu; Cao, Xuedi; Zhang, Lijie; Yang, Yang; Hou, Tianzhong; Qi, Xuan; Yang, Yumeng; Wang, Yue; Bai, Tao; Feng, Duiping; Yang, Xiaomei; He, Junqi
肿瘤
肿瘤免疫
信号转导
肾癌
MAPK/ERK
MAG
细胞生物学
发表日期：2025
文献求助 收藏

Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD)

代谢功能障碍相关脂肪肝病（MASLD）发生发展过程中分子表达模式的生物信息学分析

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-90744-3
Lan, Yuanfeng; Song, Ran; Feng, Duiping; He, Junqi
脂肪肝
代谢
发表日期：2025
文献求助 收藏

PDZK1 inhibits MRP2-mediated oxaliplatin chemosensitivity in hepatocellular carcinoma.

PDZK1抑制肝细胞癌中MRP2介导的奥沙利铂化疗敏感性

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-98085-x
Duan Zeqi, Li Jinyu, Ren Chao, Chen Yi, Feng Duiping, Ma Yanbo, Zhao Chunjuan
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Color-coded parametric imaging support display of vessel hemorrhage-an in vitro experiment and clinical validation study

彩色编码参数成像支持血管出血的显示——一项体外实验和临床验证研究

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2024.1387421
Chen, Yi; Xu, Wenji; Liu, Jiaxin; Zhao, Chao; Cao, Xiaojing; Wang, Rong; Feng, Duiping; Zhang, Ruiping; Zhou, Xiang
发表日期：2024
文献求助 收藏

Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS

术前IL-6水平与经颈静脉肝内门体分流术（TIPS）后肝硬化患者显性肝性脑病（HE）的相关性

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000128
Li, JinYu; Liu, Yang; Li, ManBiao; Rong, XueTong; Yuan, Zhen; Ren, Chao; Liu, Shuai; Li, Lei; Zhao, Chao; Gao, Long; Feng, DuiPing
IL-6
肝硬化
神经科学
发表日期：2023
文献求助 收藏

The Relationship and Changes of Liver Blood Supply, Portal Pressure Gradient, and Liver Volume following TIPS in Cirrhosis

肝硬化患者行经颈静脉肝内门体分流术后肝脏血供、门静脉压力梯度和肝脏体积的关系及变化

期刊:Canadian Journal of Gastroenterology and Hepatology
影响因子:2.3
doi:10.1155/2022/7476477
He, Jinghong; Li, Jinyu; Fang, Changxing; Qiao, Ying; Feng, Duiping
肝硬化
发表日期：2022
文献求助 收藏

Prognostic significance of controlling nutritional status score-based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation

射频消融术后，基于营养状况评分的列线图对符合米兰标准的肝细胞癌患者的预后意义

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo-20-225
Yang, Yi; Ye, Feng; Xin, Yujing; Wang, Yanan; Li, Xiao; Feng, Duiping; Chen, Yi; Zhou, Xiang
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker

SERPINH1在透明细胞肾细胞癌中的过表达：与不良临床预后相关及其作为新型预后标志物的潜力

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.2
doi:10.1111/jcmm.13495
Qi, Yijun; Zhang, Yue; Peng, Zhiqiang; Wang, Lei; Wang, Kaizhen; Feng, Duiping; He, Junqi; Zheng, Junfang
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2018
文献求助 收藏